How AI helps scientists design the next generation of medicines
Designing and developing a new medicine is an expensive, failure-prone scientific challenge. A new drug can take many years to develop, at the cost of a significant investment. And even then, most possible candidates never reach the patient. For biologic medicines, therapies made from engineered proteins rather than synthetic chemistry (which are often used to treat conditions across most major acute and chronic diseases), the complexity is even greater. Scientists explore vast quantities of pos
The tech section covers stories about technology making life better, not just more profitable. Open-source tools reaching new audiences, accessibility breakthroughs, AI applications in healthcare and education, infrastructure improvements that quietly make cities work better. Product launches and funding rounds are excluded unless they deliver tangible public benefit.
The megarocket pulls off a soft splashdown in the Indian Ocean an hour after launch.
SpaceX launches 13th Starship test, briefly deploys first upgraded Starlinks Reuters
Nvidia, Microsoft and other tech giants back open-source AI models Reuters
India's HCLTech to invest $1.48 bln in AI data center, open 5,000-seat tech hub Reuters